baber/WOPTO huggingface dataset:
Patent NZ-334849-A (NZ)
Title: Antimycotic gel with high active substance release for the prophylatic treatment of skin mycoses
Inventor: BOHN MANFRED
IPC: A61K9/00
Filed: 1997-09-16
Abstract: A pharmaceutical preparation for treatment and prophylaxis of dermatomycoses comprises a compound of formula (I), a hydrophilic gel forming agent, a wetting agent or spreading agent and water. In formula (I); R1, R2 and R3 are H or a C1-C4 alkyl, and R4 is saturated C6-C9 hydrocarbon radical. Examples of the preparation are: 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2(1H)pyridone 0.5%, Hydroxyethylcellulose  1.5%, Polyethylene glycol-7 glycerylcocoate  5.0%, 1,2-propylene glycol 10.0%, Isopropyl alcohol 20.0%, Demineralised water   63.0%  1-Hydroxy-4-methyl-6-cyclohexyl-2(1H)pyridone                                        1.0%, Polyacrylic acid polymer 0.7%, Sodium hydroxide 0.2%, Sodium dioctylsulfosuccinate  0.05%, 2-octyldodecanol 7.5%, Isopropyl alcohol 25.0%, Demineralised water 65.55%
Patent NZ-503886-A (NZ)
Title: Devices for manually or automatically removing indicators from garment hangers using plate having pin moving within plate recess
Inventor: MARSHALL DAVID J
IPC: A47G25/32
Filed: 1996-02-02
Abstract: Pin 120 moves within a recess of  plate 107 so as to release an indicator 18 attachment device on hanger 1.  The apparatus may be operated manually or automatically.
Patent NZ-505813-A (NZ)
Title: Numerous fatty acids and derivatives thereof in a composition derived from a secretion from around the mammary gland
Inventor: PAGEAT PATRICK
IPC: A61K35/55
Filed: 1999-01-21
Abstract: Described are compositions comprising a mixture of fatty acids such as linoleic, oleic and palmitic acids or derivatives thereof derived from secretions of mammalian mammary glands.  These compositions comprise specific fatty acids and concentrations thereof and are derived from the analysis by gas chromatography/mass spectroscopy of the secretions.  The compositions can be utilized to decrease stress, anxiety and aggressiveness in non-human mammals.
Patent NZ-507477-A (NZ)
Title: A prophylactic composition
IPC: A01N43/52
Filed: 1999-04-13
Abstract: A biocidal composition that contains a source of free phosphite ions selected from phosphorous acid and phosphite compounds capable of releasing phosphite ions at a pH of below 4 and the pH and at least one biocide.  The composition is in the form of either a solution carried by a liquid selected from water and polar solvents, or as a solids mix soluble in a liquid solvent selected from water and polar solvents.  The biocide is selected from benzimidazoles, precursors of benzimidazoles, substituted morpholines, organic chelate complexes of metals, precursors of such organic complexes of metals, metal ions selected from rhw group Al, Co, Cu, Mn, No, Ni, Wo, Va and Zn., the composition containing greater than 10% biocide by weight.
Patent NZ-507722-A (NZ)
Title: A scintillation proximity assay for the detection of peptidoglycan synthesis
Inventor: DESOUSA SUNITA
IPC: C12M1/34
Filed: 1999-05-04
Abstract: Described is a scintillation proximity assay for detecting peptidoglycan synthesis.  The assay is especially suitable for high throughput screening of compounds affecting peptidoglycan synthesis.
Patent NZ-509306-A (NZ)
Title: Nocathiacin antibiotics
Inventor: LEET JOHN E
IPC: A61P31/04
Filed: 1999-07-13
Abstract: A nocathiacin compound of the given formula (I) wherein; R is H or OH; W is H or formula (II); or  a pharmaceutically acceptable salt. The compound is useful in treating bacterial infections.
Patent NZ-509476-A (NZ)
Title: Apparatus for cutting or profiling pipe or tube with insertion section, cutting blade(s) and connection section for connection to rotating device
Inventor: ASHFORD BRIAN
IPC: B23B5/16
Filed: 2001-01-23
Abstract: One end of the tool is connected to a source of rotation such as an electric drill (not shown). The other end of the tool has a cylindrical portion to match the bore of a pipe (not shown) to be cut square.
Patent NZ-513013-A (NZ)
Title: Biodegradable ceramic fibres from silica sols useful in delivery devices for biologically active agents
Inventor: JOKINEN MIKA
IPC: A61K9/70
Filed: 2000-02-21
Abstract: A controlled biodegradable silica fibre is spun from the silica sol wherein the biodegradable rate of the fibre is adjusted by controlling the starting point of the spinning process.  The starting point is determined by the viscosity of the silica sol wherefrom the fibre is spun.  The solubility of the fibre in a simulated body fluid is 0.02-20 wt%/h.  The fibre is used in a delivery device for delivering medicines.
Patent NZ-518851-A (NZ)
Title: Sorting apparatus and method
Inventor: KENNEDY HAMISH ALEXANDER NIGEL
IPC: B65G47/52
Filed: 2002-05-08
Abstract: A sorting apparatus (1) including a first conveyor (2) which in use will convey a plurality of products to be sorted and a second conveyor (5) adapted to move relative to first conveyor to selectively receive products from the first conveyor. The second conveyor having a plurality of discrete product receiving means, which are able to receive a plurality of products, wherein the sorting apparatus is controllably operated to discharge product from the first conveyor to the second conveyor and wherein the location of discharge is not fixed.
Patent NZ-524778-A (NZ)
Title: Dispensing machine having a selective release mechanism to control the purchasing of cigarettes
Inventor: WATTS GRAHAM
IPC: G07F9/02
Filed: 2001-09-07
Abstract: A cigarette dispensing machine (1) for use in a venue with a release mechanism for selectively dispensing cigarettes to a purchaser, including a device which is actuable to selectively enable operation of the release mechanism and an associated remote control (8), arranged whereby the remote control (8) is operated in response to a visual check of age identification of a purchaser by an authorised person (10) at the venue, so as to allow a purchaser to dispense cigarette from the machine (1).
Patent NZ-525722-A (NZ)
Title: Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
Inventor: GHOSAL ANIMA
IPC: A61K31/70
Filed: 2001-12-17
Abstract: A compound of formula I, preferably of formula III, a pharmaceutical composition comprising said compound and the use of the composition in the preparation of a medicament for combined or separate use with a cholesterol biosynthesis inhibitor for treating or preventing atherosclerosis or reducing the cholesterol levels in a mammal.
Patent NZ-526282-A (NZ)
Title: Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens
Inventor: FERNANDEZ MOLINA LUIS ENRIQUE
IPC: A61P35/00
Filed: 2003-06-04
Abstract: A pharmaceutical composition enhancing the immunogenicity of poorly immunogenic antigens, containing: A) One or more poorly immunogenic antigens; B) One vaccine carrier consisting of proteoliposomes derived from the Outer Membrane Complex of Gram-negative bacteria strain (Neisseria meningitidis), which has gangliosides incorporated therein by hydrophobic bonds; and C) Eventually one or more adjuvants. The poorly immunogenic antigens may be selected from the group consisting of peptides, polypeptides, proteins, or their corresponding nucleic acid sequences, or target cells with vaccine interest, or lysates thereof, or combinations thereof. How to prepare said immunostimulating compositions which are capable of generating antigen-specific immune responses even in immuno-compromised hosts such as those suffering from cancer and chronic viral or bacterial infections is disclosed. By administering the vaccine compositions disclosed to these patients, it is possible to restore the functionality of sectors of their immune system. The vaccine compositions can be used to protect against or treat infectious, malignant and autoimmune diseases.
Patent NZ-526655-A (NZ)
Title: Use of (R)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
Inventor: BERTINI RICCARDO
IPC: A61P9/10
Filed: 2002-01-30
Abstract: (R)-ibuprofen methanesulfonamide or a non-toxic salt thereof is used in the manufacture of a medicament for the prevention or the treatment of ischemia/reperfusion injury of transplanted organs or of functional injury resulting from rejection reactions of transplanted organs.
Patent NZ-530194-A (NZ)
Title: Hard bouillon tablet and a process for production of a hard bouillon tablet
Inventor: PALZER STEFAN
IPC: A23L27/00
Filed: 2002-05-27
Abstract: A hard bouillon tablet comprises only or mainly oil and no or little fat. A process for the production of the hard bouillon tablet is also described.
Patent NZ-530641-A (NZ)
Title: Method of producing a coated fibrous web
Inventor: NISSINEN KIRSI
IPC: D21H19/38
Filed: 2002-06-25
Abstract: Describes a method of producing a calendered, coated fibrous web, according to which method a fibrous web is coated with a coating colour containing a coating pigment, and the coated fibrous web is calendered. At least 1 % of the pigment is comprised of calcium oxalate, and the coated web is calendered by online calendering.
Patent NZ-531604-A (NZ)
Title: Method for transfer of particulate solid products between zones of different pressure
Inventor: CHRISTENSEN LENA HOLM
IPC: B01J3/02
Filed: 2002-07-22
Abstract: The method invented is based on a sluice system according to which the product is first conveyed through a portioning device, which produces a sequence of uniform product portions divided by uniform particle free spaces, and subsequently the product portions are conveyed individually through a sluice device, which comprises at least one sluice chamber and two pressure locks of which at least one at any time secures a pressure tight barrier between the two pressure zones, and the product portions are force loaded from the first zone into a sluice chamber by means of a piston screw, the axis of which is practically in line with the axis of the sluice chamber, and the product portions are force unloaded from the sluice chamber and into the second pressure zone by means of said piston screw or a piston or by means of gas, steam or liquid supplied at a pressure higher than that of the second pressure zone.
Patent NZ-532781-A (NZ)
Title: Supplementary endo-capsular lens and method of implantation
Inventor: HO ARTHUR
Filed: 2001-05-08
Abstract: A method of inserting and embedding a supplemental endo capsular lens (SECL) within either a gel or polymer, inside the capsule of the crystalline lens of a non-human animal, during phaco-ersatz or similar surgical procedures in order to supplement the refractive power of the eye with a view to (1) correcting ametropia while (2) maintaining a useable amplitude of accommodation.
Patent NZ-536361-A (NZ)
Title: Treatment of alpha-galactosidase a deficiency
Inventor: TRECO DOUGLAS A
IPC: C12Q1/54
Filed: 2003-04-25
Abstract: Disclosed is method for classifying an alpha-Galactosidase A (a-Gal A) preparation, the method comprising: obtaining or providing a first test a-Gal A preparation; and determining if the first test a-Gal A preparation has one or more of the characteristics (1)-(7): (1) has at least about 75% neutral, mono- and di-sialylated glycans combined; (2) has less than about 35% tri- and tetra-sialylated glycans combined; (3) has greater than 50% complex glycans; (4) has less than about 45% phosphorylated glycans; (5) has greater than about 45% sialylated glycans; (6) has a ratio of sialic acid to mannose-6-phosphate on a mole per mole basis greater than 1.5 to 1; and (7) has a ratio of sialylated glycans to phosphorylated glycans greater than 1, wherein the determination is used to classify the a-Gal A preparation, thereby analyzing an a-Gal A preparation. Also disclosed is a method for analyzing an a-Gal A preparation, the method comprising: obtaining or providing a test a-Gal A preparation; and determining one or more of: (1) if the serum clearance from human circulation is less than 425 mL/min/kg on the linear portion of the AUC vs. dose curve; (2) if the preparation is preferentially targeted to capillary/vascular endothelial cells, renal glomerular epithelial cells (podocytes), glomerular mesangial cells, renal endothelial cells, pulmonary cells, renal cells, neural cells, or cardiac myocytesin a subject, and (3) is not taken up by liver hepatocytes, wherein the determination is used to classify the a-Gal A preparation, thereby analyzing an a-Gal A preparation. The possession of at least one of the above characteristics indicates that the preparation is positively correlated with desirable pharmacokinetic parameters or biological activity.
Patent NZ-540426-A (NZ)
Title: Camomile/aloe vera treated glove
Inventor: LOO LIONG YU
IPC: A45D40/26
Filed: 2003-12-08
Abstract: Disclosed herein is a treated glove wherein the interior surfaces of the glove comprise water, glycerol and a botanical extract. Also disclosed is the composition of the film and the process for applying the film onto the interior surfaces of the glove.
Patent NZ-548716-A (NZ)
Title: Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir
Inventor: PAN LI-WEI
IPC: A61K9/00
Filed: 2005-02-09
Abstract: Disclosed are an apparatus and a method for preventing backflow into a beneficial agent reservoir of an osmotic delivery system when dispensing the beneficial agent.
Patent NZ-551747-A (NZ)
Title: A plank
Inventor: LAVENDER DOUGLAS
Filed: 2006-12-01
Abstract: A plank having a longitudinally extending plank front face and a longitudinally extending plank rear face, with the plank front face and plank rear face extending between longitudinally extending edge faces, said plank including: a longitudinally extending body having the plank front face and having a longitudinally extending body rear face; and a longitudinally extending insulation layer fixed to the body rear face and having said plank rear face, with said plank front face converging towards said plank rear face in a direction transverse of the plank.
Patent NZ-553149-A (NZ)
Title: Use of inositol hexaphosphate or inositol hexasulphate to complex biologically active compounds for the preparation of controlled release pharmaceutical compositions
Inventor: YUHUA LI
IPC: A61K9/54
Filed: 2005-08-11
Abstract: Disclosed is a pharmaceutical composition which comprises: a) a complex of a biologically active compound having at least one basic functional group and a polyanion that is inositol hexaphosphate or inositol hexasulphate; and b) a pharmaceutically acceptable carrier comprising a biodegradable, water-insoluble polymer. Also disclosed is the use of the above pharmaceutical composition in the manufacture of a sustained, controlled release medicament for treating warm-blooded animals in need of such treatment. Additionally, a process for the preparation of the above composition is also disclosed, comprising: a) separately dissolving a biologically active compound having at least one basic functional group, and a polyanion that is inositol hexaphosphate or inositol hexasulphate; and b) mixing the dissolved biologically active compound and polyanion to produce a complex; and c) dispersing the complex into a pharmaceutically acceptable carrier comprising a biodegradable, water-insoluble polymer.
Patent NZ-553457-A (NZ)
Title: Driver blade with auxiliary combustion chamber for combustion powered fastener-driving tool
Inventor: PANASIK CHERYL L
IPC: B25C1/08
Filed: 2005-08-28
Abstract: A driver blade 40 for use in a combustion-powered fastener-driving tool comprises an elongate tubular body 42 having a combustion end 44, a central portion and a driving end 48, the combustion end 44 being configured for attachment to a piston 28, and the driving end 48 having a solid cross-section. The body has a hollow interior defining a driver blade chamber 48 extending through the combustion end 44 into the central portion.
Patent NZ-553562-A (NZ)
Title: Process for production of (S)-2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylamine
Inventor: URAYAMA SHINICHI
IPC: A61K31/343
Filed: 2005-09-12
Abstract: Disclosed is a process for producing (S)-2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethylamine or a salt thereof, which comprises step (i): a step for asymmetrically reducing (E)-2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-ylidene)ethylamine or a salt thereof with a catalyst, and step (ii): a step for catalytically reducing the reaction product obtained in step (i) at a reaction temperature of 40 deg C to 100 deg C and pH 3 to 9 with a catalyst.
Patent NZ-556623-A (NZ)
Title: A beehive lid which avoids propolis around the lids opening
Inventor: KATSAMPIS IOANNIS
IPC: A01K47/00
Filed: 2006-02-08
Abstract: A beehive lid is disclosed. The lid includes a top cover that opens using a connecting mechanism (1), there are containers (8) under the top cover (10) for placement of liquid, and a surface (24, 25) attached to the sidewalls (2) of the lid. The surface has an opening (9) that is covered by a removable cover (48). One side (26) of the surface of the lid is inclined coming down into the containers leaving a gap between its end and the bottom (30) of the container (8). The liquids are transferred through the gap inside the body of the lid (99) to a space (7). The space is defined by walls having stripes to help the bees to climb up easily, and prevent immediate contact with the top (10) of the lid so they do not glue it with "propolis". This gives immediate access to the liquids in the containers (8) without having any contact with the bees and gives the ability to open the removable cover (48) to place anything inside or take anything out. On the top of the lid (10) there are shutters (11) that open and are adjustable to help the bees overcome any extreme weather conditions. When the shutters are closed, they cover the air intake holes. All the above are done without taking the lid (99) off and without smoking the bees, this avoids transferring the toxic substances of the smoke to the bees' products.
Patent NZ-571801-A (NZ)
Title: Composition for aqueous coating material, method for producing the same, and two-component curable aqueous coating material kit
Inventor: SUMI NAOKO
IPC: C09D5/00
Filed: 2007-04-25
Abstract: Disclosed is a composition, which comprises water and a synthetic resin dispersed or dissolved therein, wherein the synthetic resin contains a fluorinated copolymer (A) comprising from 40 to 60 mol percentage of a structural unit of the formula (a1) e.g. chlorotrifluoroethylene, from 3 to 50 mol percent of a structural unit of the formula (a2) e.g. ethyl vinyl ether, from 4 to 30 mol percent of a structural unit of the formula (a3) e.g. hydroxyl butylvinyl ether and 1.4 to 6 mol percent of a structural unit of the formula (a4) e.g. hydroxyl butyl vinyl succinate (provided that the total mol percent value of the respective structural units of the formulae (a1), (a2), (a3) and (a4) is from 80 to 100); and which contains no organic solvent or an organic solvent in an amount of at most 3 mass percent in the total mass of the composition for aqueous coating material wherein Formula (a1) is ) CFX1-CX2X3 wherein X1 - X3 is defined in the specification and Formula (a2) - (a4) substituents are defined in the specification.
Patent NZ-572056-A (NZ)
Title: System for medical bed transport with vertical control handle coupled to control arm attached to bed frame
Inventor: STROH GLENN
IPC: A47C21/00
Filed: 2007-04-13
Abstract: Disclosed is a system for transporting a bed (100) which comprises a bed frame (120). The system includes: a drive system (110), a first control arm (140), a vertical control handle coupled to the control arm, and a first switch on the first control handle. The drive system and control arm are coupled to the bed frame, the drive system providing a powered movement of the bed frame. The switch controls a function of the drive system.
Patent NZ-573040-A (NZ)
Title: Cable railway system
Inventor: MORITZHUBER JOHANNES
IPC: B61B1/02
Filed: 2008-11-21
Abstract: A cable railway system with transport vehicles (3) that decouple from a conveying cable (1) at stations to allow passengers to embark and disembark is disclosed. At the stations the decoupled vehicles move along paths defined by guide rails (4). The station has at least two diverter switches (41, 42) to divert respective vehicles of a first group to move along a first path (4a), and vehicles of a second group to move along a second path (4b). A common entry and exit area (10) for passengers is located between the first and second guide paths. Access doors on the first group and second groups of vehicles face towards the common entry and exit area. The use of two separate paths doubles the number of cable cars available to passengers without additional space being required at the station.
Patent NZ-576007-A (NZ)
Title: Engine where the axis of the pairs of cylinders are at an angle that depends on the number of lobes on a cam
Inventor: HOWELL-SMITH BRADLEY
IPC: F01B9/06
Filed: 2007-09-07
Abstract: An internal combustion engine comprising at least one cylinder module is disclosed. The cylinder module comprises a shaft (6), two pair of cylinders and a piston (1a, 1b) in each cylinder. The shaft (6) includes a first multilobate cam (5a) and a second multilobate cam (5b). The first multilobate cam (5a) is axially fixed to the shaft (6). The second multilobate cam (5b) is differentially geared to the first multilobate cam (5a) for axial counter rotation about the shaft (6). The two pairs of cylinders are associated with the multilobate cams (5a and 5b). The cylinders of each pair are diametrically opposed with respect to the shaft (6) with the multilobate cams (5a and 5b) inter-imposed in between. The piston (1a and 1b) in each cylinder is rigidly interconnected. Each multilobate cam (5a and 5b) comprises 3+n lobes, where n is zero or an even number integer. The axes of the pairs of cylinders are at an angle to each other of half of the number obtained by dividing 360 degrees by the number of lobes on one of the cam (5a and 5b). The reciprocating motion of the pistons (1a and 1b) in the cylinders imparts rotary motion to the shaft (6) via contact between the pistons (1a and 1b) and the camming surfaces of the multilobate cams (5a and 5b).
Patent NZ-576074-A (NZ)
Title: High-pressure forming process for tobacco material
Inventor: FRANKE DIETMAR
IPC: A24B3/14
Filed: 2007-12-05
Abstract: Disclosed herein is a method for producing tobacco material. In said method, a starting tobacco material is headed and is brought, in the first stage of the method, to a first elevated pressure; the tobacco material is then pumped to a second elevated pressure which is greater than the first elevated pressure in the second stage of the method; and is then heated and pressurised tobacco material is decompressed and is guided through a shaping tool (23). Also disclosed is an device of producing said tobacco material, comprising a heatable pressure chamber (1) that is fitted with a tobacco material inlet, a tobacco material outlet, and a conveyer mechanism (5) for conveying the tobacco material from the inlet to the outlet and increasing the pressure of the material to a first elevated pressure, and having a forming tool by means of which the tobacco, heated and placed under pressure, is conveyed, expanded by way of a sudden decrease in pressure, and formed into fibers, characterised in that a mechanical pump (7) is integrated between the pressure chamber and the forming tool which pulps the tobacco material to a second increased pressure which I s higher than the first increased pressure.